Table 1.
Dose group | LLNA (DPM) | % IgE + B220 + (% lymphocyte population) | %B220 + (% lymphocyte population) | Total IgE (ng/ml) |
---|---|---|---|---|
Acetone | 208 ± 63 | 1.08 ± 0.49 | 13.91 ± 0.82 | 446 ± 106 |
2,3-Hexanedione | ||||
12.5% | 385 ± 93 | 0.60 ± 0.31 | 16.22 ± 0.98 | 347 ± 78 |
25% | 829 ± 257 | 1.39 ± 0.57 | 17.26 ± 0.94 | 409 ± 25 |
50% | 3075 ± 720** | 10.04 ± 2.69* | 26.73 ± 1.03* | 371 ± 133 |
Acetone | 208 ± 63 | 1.08 ± 0.49 | 13.91 ± 0.82 | 445 ± 106 |
3,4-Hexanedione | ||||
12.5% | 273 ± 77 | 0.95 ± 0.61 | 17.14 ± 1.46 | 353 ± 62 |
25% | 1385 ± 390 | 4.18 ± 1.01 | 24.02 ± 2.38 | 325 ± 61 |
50% | 3745 ± 334** | 21.66 ± 3.11** | 29.21 ± 1.80** | 401 ± 45 |
Acetone | 274 ± 49 | 1.23 ± 0.28 | 14.88 ± 1.59 | 354 ± 103 |
2,3-Heptanedione | ||||
12.5% | 497 ± 97 | 1.71 ± 0.27 | 12.69 ± 1.22 | 491 ± 146 |
25% | 2421 ± 252** | 4.62 ± 0.92 | 17.05 ± 1.31 | 338 ± 54 |
50% | 3970 ± 415** | 22.26 ± 0.81** | 26.26 ± 1.28* | 587 ± 189 |
Acetone | 389 ± 45 | 1.27 ± 0.11 | 10.29 ± 10.37 | 292 ± 110 |
2,3-Pentanedione | ||||
12.5% | 560 ± 77 | 1.73 ± 0.47 | 12.20 ± 1.21 | 374 ± 118 |
25% | 1584 ± 453 | 2.04 ± 1.18 | 15.00 ± 1.56 | 337 ± 120 |
50% | 5230 ± 1152** | 15.56 ± 1.14** | 20.55 ± 2.21* | 483 ± 143 |
Acetone | 578 ± 116 | 1.50 ± 0.75 | 15.40 ± 1.05 | 332 ± 117 |
Diacetyl (Aldrich) | ||||
12.5% | 1060 ± 110 | 2.59 ± 0.97 | 17.09 ± 1.29 | 387 ± 65 |
25% | 2392 ± 536** | 7.06 ± 1.54* | 20.15 ± 1.91 | 450 ± 144 |
50% | 4770 ± 430** | 14.86 ± 4.32** | 28.89 ± 1.56* | 521 ± 133 |
Bars represent means ± SE of 5 mice per group.
Levels of statistical significance are denoted as *(p ≤ 0.05) and **(p ≤ 0.01) as compared to acetone vehicle.